|
1
|
Duchman KR, Gao Y and Miller BJ:
Prognostic factors for survival in patients with high-grade
osteosarcoma using the surveillance, epidemiology, and end results
(SEER) program database. Cancer Epidemiol. 39:593–599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maugg D, Rothenaigner I, Schorpp K,
Potukuchi HK, Korsching E, Baumhoer D, Hadian K, Smida J and
Nathrath M: New small molecules targeting apoptosis and cell
viability in osteosarcoma. PLoS One. 10:e01290582015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manley S, Williams JA and Ding WX: Role of
p62/SQSTM1 in liver physiology and pathogenesis. Exp Biol Med
(Maywood). 238:525–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moscat J and Diaz-Meco MT: p62 at the
crossroads of autophagy, apoptosis, and cancer. Cell.
137:1001–1004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inoue D, Suzuki T, Mitsuishi Y, Miki Y,
Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, et
al: Accumulation of p62/SQSTM1 is associated with poor prognosis in
patients with lung adenocarcinoma. Cancer Sci. 103:760–766. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo RZ, Yuan ZY, Li M, Xi SY, Fu J and He
J: Accumulation of p62 is associated with poor prognosis in
patients with triple-negative breast cancer. Onco Targets Ther.
6:883–888. 2013.PubMed/NCBI
|
|
10
|
Inui T, Chano T, Takikita-Suzuki M,
Nishikawa M, Yamamoto G and Okabe H: Association of p62/SQSTM1
excess and oral carcinogenesis. PLoS One. 8:e743982013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burdelski C, Reiswich V, Hube-Magg C,
Kluth M, Minner S, Koop C, Graefen M, Heinzer H, Tsourlakis MC,
Wittmer C, et al: Cytoplasmic accumulation of sequestosome 1 (p62)
is a predictor of biochemical recurrence, rapid tumor cell
proliferation, and genomic instability in prostate cancer. Clin
Cancer Res. 21:3471–3479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwadate R, Inoue J, Tsuda H, Takano M,
Furuya K, Hirasawa A, Aoki D and Inazawa J: High expression of p62
protein is associated with poor prognosis and aggressive phenotypes
in endometrial cancer. Am J Pathol. 185:2523–2533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Puissant A, Fenouille N and Auberger P:
When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res.
2:397–413. 2012.PubMed/NCBI
|
|
14
|
Jawad MU and Scully SP: In brief:
Classifications in brief: Enneking classification: Benign and
malignant tumors of the musculoskeletal system. Clin Orthop Relat
Res. 468:2000–2002. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Yang TT, Wang W, Sun HH, Ma BA, Li
CX, Ma Q, Yu Z and Fan QY: Establishment and characterization of
human osteosarcoma cell lines with different pulmonary metastatic
potentials. Cytotechnology. 61:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Y, Guan GF, Chen J, Hu B, Sun C, Ma Q,
Wen YH, Qiu XC and Zhou Y: Aberrant CXCR4 and β-catenin expression
in osteosarcoma correlates with patient survival. Oncol Lett.
10:2123–2129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Ma Q, Liu T, Guan G, Zhang K,
Chen J, Jia N, Yan S, Chen G, Liu S, et al: Interleukin-6
suppression reduces tumour self-seeding by circulating tumour cells
in a human osteosarcoma nude mouse model. Oncotarget. 7:446–458.
2016.PubMed/NCBI
|
|
19
|
Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu
YC and Hung CH: Prognostic significance of p62/SQSTM1 subcellular
localization and LC3B in oral squamous cell carcinoma. Br J Cancer.
111:944–954. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Yang Z and Dong J: P62: An
emerging oncotarget for osteolytic metastasis. J Bone Oncol.
5:30–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mohamed A, Ayman A, Deniece J, Wang T,
Kovach C, Siddiqui MT and Cohen C: P62/Ubiquitin IHC expression
correlated with clinicopathologic parameters and outcome in
gastrointestinal carcinomas. Front Oncol. 5:702015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan MM, Strack S, Wild F, Hanashima A,
Gasch A, Brohm K, Reischl M, Carnio S, Labeit D, Sandri M, et al:
Role of autophagy, SQSTM1, SH3GLB1, and TRIM63 in the turnover of
nicotinic acetylcholine receptors. Autophagy. 10:123–136. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bitto A, Lerner CA, Nacarelli T, Crowe E,
Torres C and Sell C: P62/SQSTM1 at the interface of aging,
autophagy, and disease. Age (Dordr). 36:96262014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sahani MH, Itakura E and Mizushima N:
Expression of the autophagy substrate SQSTM1/p62 is restored during
prolonged starvation depending on transcriptional upregulation and
autophagy-derived amino acids. Autophagy. 10:431–441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jain A, Lamark T, Sjøttem E, Larsen KB,
Awuh JA, Øvervatn A, McMahon M, Hayes JD and Johansen T: p62/SQSTM1
is a target gene for transcription factor NRF2 and creates a
positive feedback loop by inducing antioxidant response
element-driven gene transcription. J Biol Chem. 285:22576–22591.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mathew R, Karp CM, Beaudoin B, Vuong N,
Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayes JD and McMahon M: NRF2 and KEAP1
mutations: Permanent activation of an adaptive response in cancer.
Trends Biochem Sci. 34:176–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirai H and Nakatsuru Y: Evaluating
chemical CDK inhibitors as cell death inducers. Methods Mol Biol.
1336:167–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Linares JF, Amanchy R, Greis K, Diaz-Meco
MT and Moscat J: Phosphorylation of p62 by cdk1 controls the timely
transit of cells through mitosis and tumor cell proliferation. Mol
Cell Biol. 31:105–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Duran A, Amanchy R, Linares JF, Joshi J,
Abu-Baker S, Porollo A, Hansen M, Moscat J and Diaz-Meco MT: p62 is
a key regulator of nutrient sensing in the mTORC1 pathway. Mol
Cell. 44:134–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
